Schedule 13G ownership disclosure
JASPER THERAPEUTICS INC
Security class unavailable · CUSIP: 471871103
Event date: 2021-09-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,624,606
- Percent of class
- 12.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-122325
- Form type
- SC 13G
- Filer
- Jasper Therapeutics, Inc.
- CIK
- CIK 1788028
- Filed
- Oct 04, 2021
- Reporting period
- Sep 24, 2021
- Description
- Schedule 13G beneficial ownership